EventsProhibition Partners Live Returns For Its Second Virtual Outing...

Prohibition Partners Live Returns For Its Second Virtual Outing Of 2020

-

PROHIBITION Partners LIVE is back for its second outing this year with more than 1,500 delegates set to attend the virtual event.

Running from November 17 to 20, Prohibition Partners LIVE will feature some of the industry’s leading lights over four days of virtual networking, conversations and debate.

Stephen Murphy, Managing Director of Prohibition Partners, said: “There has never been a time where the demand for cannabis has been higher, from record sales to groundbreaking research being released, the future of cannabis looks very bright.

“Despite a pending recession, cannabis will remain one of the few true growth industries, and that should be of interest to investors and governments alike.

“Having received such a rapturous reception with our inaugural conference in June, with over 1,500 delegates joining to share ideas, spark innovation and promote change, we couldn’t wait to be back.

“We believe that cannabis has the power to change the world for the better and in such a rapidly moving industry which requires constant education, regulatory clarity and international collaboration and Prohibition Partners LIVE offers the building blocks for this incredible community.”

Each day will see thought-leaders and innovators deep-dive into key sectors within the industry: 

November 17: Science & Research
November 18: Policy & Reform
November 19: Business & Investment
November 20: Culture & Innovation

As well as the theme days, running in parallel will be a number of key tracks including Cannabis Europa, Cannabis Americana, Cannabis Oceania and PSYCH, which looks at unlocking the commercial potential of psychedelics.

A fifth track, ProCapital, sponsored by Mazakali, is an investment-focused platform, showcasing opportunities across the cannabis and psychedelics landscape.

For further information and discounted tickets click on this link.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals

THE initial warm welcome to proposals to make UK cannabinoid regulations a matter for the health authorities - not...

IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions

IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC, CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational...

Always Pure Organics Makes £3m Continental Swoop For Leading B2C Hemp And CBD Player

FAST-GROWING UK cannabis wholesaler Always Pure Organics has acquired two Belgian companies - Distribution Legal Hemp and NexGen -...

Little Green Pharma Picks Up Distressed Canadian LP’s Danish Cannabis Asset for £11.6m

AUSTRALIAN company Little Green Pharma has purchased the former Canopy Growth medicinal cannabis cultivation and manufacturing facility in Denmark...

New Era Beckons For Swiss Medical Cannabis Patients After Ten Years In Slow Lane

THE impending change to Switzerland’s medical cannabis laws could see the number of patients receiving treatment rise from 3,000...

How Britain’s Three Crown Dependencies Are Stealing A Cannabis March On the Mainland

FRUSTRATED by the UK Government’s stance the three UK Crown Dependencies of Jersey, Guernsey and the Isle of Man,...

Must read

Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals

THE initial warm welcome to proposals to make UK...

Little Green Pharma Picks Up Distressed Canadian LP’s Danish Cannabis Asset for £11.6m

AUSTRALIAN company Little Green Pharma has purchased the former...

You might also likeRELATED
Recommended to you